LobbyingRochester Regional Health lobbying by quarter
Rochester Regional Health's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $280K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Rochester Regional Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $280K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $270K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $280K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $300K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $130K | 1 |
| Q1 2026 | $110K | 1 |
| Q2 2026 | $40K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$630K · 15 reports
- Health issues$630K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Agriculture, Dept of (USDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseRochester Regional Health | $1.3M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $40K |
| 04/16for Q1 | In-house | $110K |
| 03/10for Q4 2025 | In-house | $130K |
| 01/20for Q4 2025 | In-house | $10K |
| 25/10/21for Q3 2025 | In-house | $30K |
| 25/07/23for Q2 2025 | In-house | $40K |
| 25/04/21for Q1 2025 | In-house | $300K |
| 25/01/21for Q4 2024 | In-house | $10K |
| 24/10/21for Q3 2024 | In-house | $10K |
| 24/07/22for Q2 2024 | In-house | $10K |
| 24/04/21for Q1 2024 | In-house | $280K |
| 24/01/22for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | $10K |
| 23/07/19for Q2 2023 | In-house | $10K |
| 23/04/20for Q1 2023 | In-house | $270K |
| 23/01/20for Q4 2022 | In-house | $10K |